Cost effectiveness of quality control in bacteriology

Area of Science:

• Medical Laboratory Science
• Clinical Microbiology
• Health Economics

Background:

• Regulatory quality control (QC) in bacteriology lacks established cost-effectiveness.
• Evaluating surveillance procedures is crucial for optimizing laboratory efficiency.

Purpose of the Study:

• To assess the cost-effectiveness of regulatory-mandated quality control (QC) procedures in bacteriology.
• To compare the deficiency detection rates and costs of different QC approaches.

Main Methods:

• Evaluated 111 surveillance procedures across 54 operations, including CLIA-compliant (CLIA-P), modified CLIA-compliant (CLIA-PM), and author-devised (HH-P) methods.
• Analyzed deficiency detection rates, percentages, and mean percentages for each procedure type.
• Calculated the annual costs associated with CLIA compliance and proposed modifications.

Main Results:

• CLIA-P detected 67% of deficiencies (3.5% mean), CLIA-PM detected 22% (2.1% mean), and HH-P detected 100% (8.8% mean).
• Full CLIA compliance costs $20,700/year, while HH-P adds $9,000/year.
• Optimizing QC by discontinuing low-yield CLIA-P and targeting specific reagents/media can save significant costs.

Conclusions:

• Current regulatory QC in bacteriology may not be cost-effective.
• Modified or internally developed QC procedures can enhance deficiency detection and reduce laboratory expenses.
• Strategic adjustments to QC protocols offer substantial financial benefits without compromising quality.